Intervention in AAK1 catalysis has also been explored for potential therapies in the treatment of viral diseases including HCV, dengue virus and ebola virus (DEVN), bacterial sepsis, rabies virus (RABV), and COVID-19 (Figure 6). The gene discussed is AAK1; the disease is COVID-19.